Market News

3 Stocks in Focus: Himadri +13%, UTI AMC -10%, Cyient -7% Amid Heavy Volumes

April 24, 2026
5 min read

Key Points

Himadri surged 13% on strong Q4 earnings, margin expansion, and growing demand in specialty chemicals and EV-linked materials.

UTI AMC fell 10% after weak profit performance and pressure on asset management income amid volatile market conditions.

Cyient declined 7% due to muted revenue growth, profit drop, and ongoing weakness in the global IT sector.

Market trend stayed stock-specific, with heavy volumes showing investors focusing more on earnings strength than overall index movement.

We saw a highly stock-specific trading session today. The broader market stayed weak, but individual stocks moved sharply based on earnings and heavy volumes. It was not an index-driven day. It was a stock-picking day. Three names clearly stood out. Himadri Speciality Chemical surged nearly 13%. UTI Asset Management fell around 10%. Cyient dropped close to 7%. The reaction was fast, sharp, and clearly driven by results and investor sentiment. The main theme today was simple. Strong earnings were rewarded. Weak earnings were punished. Volume spikes confirmed strong institutional participation across all three stocks.

Market Background & Heavy Volume Trend

  • Market Sentiment: The overall market stayed weak due to cautious global cues and sector rotation.
  • Index Action: Broader indices moved sideways, but stock-specific moves were strong.
  • Heavy Volume Activity: Trading volumes stayed unusually high across mid and large caps.
  • Institutional Flow: Higher participation from institutional traders was clearly visible.
  • Earnings Reaction: Strong buying in good results, heavy selling in weak results.
  • Volatility: Sharp intraday swings were seen in multiple stocks.
  • Key Takeaway: The market is in a selective phase where earnings matter more than indices.

 Himadri Speciality Chemical: +13% Rally on Strong Earnings

  • Stock Move: Himadri surged nearly +13% intraday and hit a fresh record high.
  • Volume Trend: Strong volume spike indicated heavy institutional buying interest.
  • Profit Growth: Q4 net profit jumped 29%–33% YoY, around ₹201–₹207 crore.
  • Revenue Growth: Revenue rose to nearly ₹1,287–₹1,349 crore.
  • Margin Strength: EBITDA margins improved, showing better operational efficiency.
  • Key Driver: Expansion in specialty chemicals and carbon materials business.
  • EV Theme: Growth in battery and anode materials supported sentiment.
  • Capacity Update: New production facility in West Bengal added long-term visibility.
  • Investor Sentiment: Strong earnings + EV theme attracted fresh buying.
  • Key Outlook: Rally is fundamental, but it depends on execution and demand stability.

UTI AMC: -10% Fall on Weak Results

  • Stock Move: UTI AMC fell nearly 10% in a single session with heavy volumes.
  • Profit Pressure: Earnings showed weakness and lower profitability growth.
  • Income Slowdown: Asset management income growth slowed compared to expectations.
  • AUM Impact: Market volatility affected overall AUM sentiment.
  • Key Concern: Weak equity inflows reduced near-term earnings visibility.
  • Cost Pressure: Rising operating costs added further pressure on margins.
  • Market Reaction: Short-term panic selling dominated despite long-term AMC strength.
  • Investor View: Focus shifted to weak quarterly performance over future potential.
  • Outlook: Recovery depends on SIP inflows, market stability, and cost control.

 Cyient: -7% Drop on Profit Decline

  • Stock Move: Cyient declined nearly 7% amid heavy selling pressure.
  • Profit Trend: Net profit declined, showing weaker earnings performance.
  • Revenue Growth: Revenue remained nearly flat at around ~1% YoY growth.
  • Margin Pressure: Engineering services margins came under pressure.
  • Global Factor: Weak IT spending impacted the demand outlook.
  • Demand Issue: Discretionary outsourcing demand stayed soft globally.
  • Sector Pressure: Broader IT sector weakness added to the decline.
  • Guidance Concern: Weak expectations increased selling pressure.
  • Outlook: Long-term aerospace strength exists, but short-term pressure continues.

Comparative Analysis: Why Stocks Moved Differently

  • Himadri (+13%): Strong earnings growth + EV-linked expansion boosted demand.
  • UTI AMC (-10%): Profit decline + weak flows created selling pressure.
  • Cyient (-7%): IT slowdown + margin pressure dragged the stock lower.
  • Key Pattern: Earnings surprise drove sharp divergence across stocks.
  • Market Behavior: Investors rewarded growth and punished uncertainty.
  • Volume Signal: High volumes confirmed active institutional repositioning.
  • Main Insight: Stock movement is now driven more by earnings than market trend.

Conclusion

Today’s market session clearly showed that stock-specific movements are driving the overall trend rather than the broader index direction. Himadri stood out with a strong double-digit gain, supported by solid earnings growth, expanding capacity, and long-term positioning in the specialty chemicals and EV-related materials space. On the other hand, UTI AMC came under heavy pressure due to weak profitability and concerns over near-term earnings stability in the asset management space. Cyient also declined as softer IT demand and margin pressure weighed on investor sentiment.

Overall, the session highlights that the market is becoming highly selective. Investors are now reacting more sharply to earnings surprises, both positive and negative. In such an environment, stock fundamentals, sector strength, and earnings quality are playing a much bigger role than general market trends.

FAQS

Why did Himadri’s share price rise today?

Himadri jumped by around 13% after strong Q4 results. Profit grew sharply, margins improved, and investor interest increased due to its expansion in specialty chemicals and EV-related materials.

Why did UTI AMC fall so much?

UTI AMC dropped nearly 10% due to weak earnings. Profit pressure, slower revenue growth, and concerns about market-linked income led to heavy selling.

What caused Cyient’s stock decline?

Cyient fell about 7% because of weak profit numbers and slow revenue growth. Global IT sector slowdown and margin pressure also affected sentiment.

What is the main takeaway from these stock moves?

The key takeaway is that the market is currently stock-specific. Strong earnings are being rewarded, while weak results are getting punished sharply.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)